Basic↦Ethics and Laws↦Human Research Ordinance↦Projects with Data and Biological Material
What is it? Why is it important?
Chapter 2 of the HRO ordinance regulates human research projects that prospectively sample or collect Biological Material (BM) and collect Health-Related personal Data (HRpD) from participants. Project aims are to:
- Answer a scientific question
- Make the data/samples available for reuse at some later date in order to answer research questions
In addition to general provisions, the HRO includes:
- The risk-categorisation of the research project based on expected risks (e.g. with A having a low and B a higher risk)
- The definition of Informed Consent (IC) procedures
- Required insurance coverage
- Ethics Committee (EC) / FOPH submission and approval
- Required safety procedures during study conduct (e.g. risk-control measures, notification of serious events)
- Notification requirements (e.g. changes or amendments, project completion or discontinuation)
What do I need to do?
In addition to general HRA responsibilities, the project leader of a chapter 2 HRO project must:
- Categorise the project based on expected risks and burdens (R&B), with category:
- A – having only minimal R&B
- B – having more than minimal R&B
- Provide insurance coverage for category B projects
- Set-up a database which guarantees data quality (e.g. traceability) and data confidentiality (e.g. data protection act)
- Take measures to protect data (e.g. coding of research data, access control, secure storage, secure data exchange)
- Define IC procedures (e.g. participant information (e.g. PIS) and recruitment)
- Ensure participants are adequately informed about the planned research project regarding:
- Expected obligations, potential safety issues, damage coverage, project results, financing
- Their right to withhold and revoke consent (regarding study participation) at any time
- Report the completion or discontinuation of a research project to EC within 90 days
More
Ensure to adhere to notification procedures, such as:
- Serious events including safety and protective measures
- Project completion or discontinuation
Multi-centre projects:
- Ensure appropriate agreements are in place between project leader and participating site(s), such as data / sample sharing agreements – DTA / MTA).
Where can I get help?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
External Links
Swissethics – see in particular
- Templates and checklists
- Study protocols / Research projects with persons
References
KOFAM: Coordination portal for human research – see in particular
- Online wizard for risk categorisation
Swiss Law
HRO – see in particular articles and chapters / sections
- Art. 6 Research project purpose
- Art. 7 Categorisation and definition of minimal risks and burdens
- Chapter 2, section 2. Authorisation procedures
- Chapter 2, section 3. Notification and reporting